Shareholders’ Deficit (Details) - USD ($)					1 Months Ended
		May 30, 2023	May 24, 2023	Mar. 08, 2023	Mar. 31, 2023
Shareholders’ Deficit (Details) [Line Items]
Preferred stock, shares authorized					5,000,000
Preferred stock, par value (in Dollars per share)					$ 0.0001
Preferred shares, shares issued
Preferred shares, shares outstanding
Aggregate shares			825,000
Class A Ordinary Shares [Member]
Shareholders’ Deficit (Details) [Line Items]
Common stock, shares authorized					500,000,000
Common stock, par value (in Dollars per share)					$ 0.0001
Ordinary shares, shares issued
Ordinary shares, shares outstanding
Aggregate percentage					20.00%
Class B Ordinary Shares [Member]
Shareholders’ Deficit (Details) [Line Items]
Common stock, shares authorized	[1]				50,000,000
Common stock, par value (in Dollars per share)	[1]				$ 0.0001
Ordinary shares, shares issued	[1]				6,325,000
Ordinary shares, shares outstanding	[1]				6,325,000
Common stock, shares issued				5,750,000	6,325,000
Common stock, shares outstanding					6,325,000
Class B Ordinary Shares [Member] | Sponsor [Member]
Shareholders’ Deficit (Details) [Line Items]
Common stock value issued (in Dollars)				$ 25,000
Price per share (in Dollars per share)				$ 0.004
Forecast [Member]
Shareholders’ Deficit (Details) [Line Items]
Capitalization of shares			575,000
Founder shares		6,250,000	6,325,000
Sponsor holding shares		75,000	6,325,000

[1] Includes up to 825,000 Class B ordinary shares that were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 7). On May 24, 2023, the Company effected a share capitalization of 575,000, resulting in the Sponsor holding 6,325,000 founder shares. On May 30, 2023, as a result of the partial exercise of the over-allotment option, the Sponsor forfeited 75,000 of these shares and the remaining Class B ordinary shares are no longer subject to forfeiture. All share and per-share data has been retroactively restated to reflect the share capitalization (Note 8).